Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
|
| gptkbp:acquiredBy |
gptkb:Johnson_&_Johnson
|
| gptkbp:acquisitionYear |
2022
|
| gptkbp:CEO |
Michael R. Minogue
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:founded |
1981
|
| gptkbp:founder |
David M. Lederman
|
| gptkbp:headquartersLocation |
gptkb:Danvers,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Abiomed
|
| gptkbp:industry |
medical devices
|
| gptkbp:notableProduct |
AbioCor artificial heart
Impella heart pump |
| gptkbp:numberOfEmployees |
~2000
|
| gptkbp:parentCompany |
gptkb:Johnson_&_Johnson
|
| gptkbp:product |
AbioCor
Impella |
| gptkbp:publiclyTraded |
gptkb:NASDAQ
|
| gptkbp:revenue |
$1.03 billion (2022)
|
| gptkbp:specializesIn |
heart pump technology
|
| gptkbp:stockSymbol |
ABMD
|
| gptkbp:website |
https://www.abiomed.com/
|
| gptkbp:bfsParent |
gptkb:Henri_Termeer
gptkb:Route_128_corridor |
| gptkbp:bfsLayer |
7
|